Nuo Therapeutics, Inc. (AURX) — Insider Trading

Key Insights

• This Form 4 filing indicates that the reporting person, Scott M. Pittman, has acquired a significant stake in Nuo Therapeutics, Inc. (AURX) through the issuance of various warrants, including Commitment Warrants, Origination Initial Warrants, Capital Initial Warrants, Origination Second Warrants, Capital Second Warrants, and Prepayment Warrants.
• The vesting of the Origination Second Warrants and Capital Second Warrants is contingent on the occurrence of a 'Second Funding' under the Loan and Security Agreement, while the Prepayment Warrants are tied to the occurrence of a 'Prepayment' event.
• The issuance of these warrants suggests that the reporting person, who is a director and 10% owner of the company, is taking a significant financial stake in Nuo Therapeutics, which could be seen as a positive signal for the company's future prospects.